t
Oxford Nanopore Technologies plc announced its participation in two investor conferences in September. CEO Francis Van Parys and CFO Nick Keher will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, 15 September at 10:45 am EDT. CFO Nick Keher will also participate in a fireside chat at the RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference on Tuesday, 22 September at 3:15 pm BST.
9 September 2026
Oxford Nanopore Technologies plc
("Oxford Nanopore" or the "Company")
Oxford Nanopore to participate in upcoming investor conferences
Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in September.
· Morgan Stanley Global Healthcare Conference, New York
Format: Fireside chat and investor meetings
Date: Tuesday, 15 September
Francis Van Parys, Chief Executive Officer, and Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 10:45am EDT (3:45pm BST).
· RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference
Format: Fireside chat and investor meetings
Date: Tuesday, 22 September
Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 3:15pm BST (10:15am EDT).
A webcast of both fireside chats will be accessible through Oxford Nanopore's Investor Relations website. The webcasts will be available for replay for at least 30 days after the event.
-ENDS-
For further information, please contact:
Oxford Nanopore Technologies plc
Investors: [email protected]
Media: [email protected]
Teneo (communications adviser to the Company)
Tom Murray, Lisa Jarrett-Kerr
+44 (0) 20 7353 4200
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.
For more information please visit: www.nanoporetech.com